Today: 29 April 2026
Browse Category

Healthcare Innovation 8 October 2025 - 16 October 2025

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (FEMY) Stock Soars 46% on Fertility Tech and FDA Milestones

Femasys (NASDAQ: FEMY) jumped 46% to $0.80 by mid-day Oct. 16 after announcing its FemaSeed fertility treatment will be showcased at ASRM 2025. The company recently secured European, UK, and New Zealand approvals for its FemBloc birth control device and reported its first European sales and new distribution deals. Q2 revenue rose 85% year-over-year to $0.409 million.
Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics (TTRX) Skyrockets After Nasdaq Debut – Biotech Breakthrough or Hype?

Turn Therapeutics shares surged to around $23 midday Oct. 9 after opening at $24.50, following a prior close of $7. Market cap jumped to over $500 million from under $100 million. The stock debuted on Nasdaq Oct. 8 via direct listing and has traded with extreme volatility, more than tripling in value amid speculative interest. No new FDA approvals were announced this week.
Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI (TEM) Stock Skyrockets on AI Healthcare Breakthroughs – What Investors Need to Know

Tempus AI shares closed at a record $102.31 on October 8, 2025, nearly tripling year-to-date after FDA clearance for new AI diagnostics and the $81.3 million acquisition of Paige. Q2 revenue surged 89.6% to $314.6 million, with net losses narrowing and positive adjusted EBITDA forecast for 2025. Market cap stands near $17 billion.

Stock Market Today

  • Smart Share Global Withdraws ADS Listing from Nasdaq
    April 29, 2026, 1:50 PM EDT. Smart Share Global Ltd has formally withdrawn its American Depositary Shares (ADS) listing from the Nasdaq Stock Market. The move was confirmed through the filing of Form 25 with the U.S. Securities and Exchange Commission, which notifies the removal of a security from exchange listing and registration. Nasdaq executed the delisting based on regulatory compliance provisions under the Securities Exchange Act of 1934. Smart Share Global, headquartered in Shanghai, China, did not disclose detailed reasons behind the withdrawal. This development marks a significant shift for the Chinese firm's market presence in the United States, raising questions about future listing strategies or market focus.

Latest article

Sagtec Global Stock Jumps After Record 2025 Revenue, but Costs Tell a Harder Story

Sagtec Global Stock Jumps After Record 2025 Revenue, but Costs Tell a Harder Story

29 April 2026
Sagtec Global reported 2025 audited revenue of $19.1 million, up 49%, driven by strong growth in services. Shares surged 38% to $2.35 in U.S. trading after volatile swings. Operating income dropped 9% to $2.1 million and earnings per share fell to $0.09 from $0.16, reflecting higher costs after the Nasdaq IPO. Net cash from operations rose 187% to $4.1 million.
Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

Dow Jones Today: Why the Blue-Chip Index Is Sliding Before Powell, Big Tech and the Oil Shock

29 April 2026
The Dow Jones Industrial Average dropped 320 points, or 0.65%, to 48,821.82 Wednesday afternoon, heading for a fifth straight loss as investors awaited the Federal Reserve’s rate decision and major tech earnings. Brent crude surged 7.14% to $119.20 after reports of a possible extended Iran blockade. Boeing and Goldman Sachs weighed on the Dow, while Amazon rose and Microsoft slipped in midday trading.
Go toTop